The presence of BRAF and TERT promoter mutations in both tumor components suggests that they may have a common origin and that, over time, the tumor cells clonally evolved by also acquiring the TP53 mutation, ultimately resulting in dedifferentiation. The gene discussed is TERT; the disease is neoplasm.